Article
Influence of CYP3A5 and MDR1 polymorphisms on tacrolimus concentration in the early stage after renal transplantation.
Clinical transplantation - 1 Oct 2005
Zhang Xin, Liu Zhi-hong, Zheng Jing-min, Chen Zhao-hong, Tang Zheng, Chen Jin-song, Li Lei-shi
Abstract excerpt
OBJECTIVE: Tacrolimus is an immunosuppressive drug with a narrow therapeutic range and wide interindividual variation in its pharmacokinetics. Cytochrome P450 (CYP) 3A and P-glycoprotein (P-gp, encoded by MDR1) play an important role in the absorption and metabolism of tacrolimus. The objective of this study was to evaluate whether or not CYP3A5*1/*3 or MDR1 C3435T polymorphisms are associated with the tacrolimus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
